Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 105

1.

Increased central microglial activation associated with peripheral cytokine levels in premanifest Huntington's disease gene carriers.

Politis M, Lahiri N, Niccolini F, Su P, Wu K, Giannetti P, Scahill RI, Turkheimer FE, Tabrizi SJ, Piccini P.

Neurobiol Dis. 2015 Aug 18. pii: S0969-9961(15)30032-2. doi: 10.1016/j.nbd.2015.08.011. [Epub ahead of print]

PMID:
26297319
2.

Loss of phosphodiesterase 10A expression is associated with progression and severity in Parkinson's disease.

Niccolini F, Foltynie T, Reis Marques T, Muhlert N, Tziortzi AC, Searle GE, Natesan S, Kapur S, Rabiner EA, Gunn RN, Piccini P, Politis M.

Brain. 2015 Jul 25. pii: awv219. [Epub ahead of print]

PMID:
26210536
3.

Altered PDE10A expression detectable early before symptomatic onset in Huntington's disease.

Niccolini F, Haider S, Reis Marques T, Muhlert N, Tziortzi AC, Searle GE, Natesan S, Piccini P, Kapur S, Rabiner EA, Gunn RN, Tabrizi SJ, Politis M.

Brain. 2015 Jul 21. pii: awv214. [Epub ahead of print]

PMID:
26198591
4.

Trend Analysis of Cancer Mortality and Incidence in Panama, Using Joinpoint Regression Analysis.

Politis M, Higuera G, Chang LR, Gomez B, Bares J, Motta J.

Medicine (Baltimore). 2015 Jun;94(24):e970. doi: 10.1097/MD.0000000000000970.

PMID:
26091467
5.

Single versus multiple impulse control disorders in Parkinson's disease: an ¹¹C-raclopride positron emission tomography study of reward cue-evoked striatal dopamine release.

Wu K, Politis M, O'Sullivan SS, Lawrence AD, Warsi S, Bose S, Lees AJ, Piccini P.

J Neurol. 2015 Jun;262(6):1504-14. doi: 10.1007/s00415-015-7722-7. Epub 2015 Apr 18.

PMID:
25893253
6.

Recent imaging advances in neurology.

Rocchi L, Niccolini F, Politis M.

J Neurol. 2015 Mar 26. [Epub ahead of print]

PMID:
25808503
7.

Molecular imaging of levodopa-induced dyskinesias.

Niccolini F, Rocchi L, Politis M.

Cell Mol Life Sci. 2015 Jun;72(11):2107-17. doi: 10.1007/s00018-015-1854-x. Epub 2015 Feb 15. Review.

PMID:
25681866
8.

The role of pallidal serotonergic function in Parkinson's disease dyskinesias: a positron emission tomography study.

Smith R, Wu K, Hart T, Loane C, Brooks DJ, Björklund A, Odin P, Piccini P, Politis M.

Neurobiol Aging. 2015 Apr;36(4):1736-42. doi: 10.1016/j.neurobiolaging.2014.12.037. Epub 2015 Jan 6.

PMID:
25649022
9.

Increased PK11195-PET binding in normal-appearing white matter in clinically isolated syndrome.

Giannetti P, Politis M, Su P, Turkheimer FE, Malik O, Keihaninejad S, Wu K, Waldman A, Reynolds R, Nicholas R, Piccini P.

Brain. 2015 Jan;138(Pt 1):110-9. doi: 10.1093/brain/awu331. Epub 2014 Nov 21.

PMID:
25416179
10.

Neuroimaging in Parkinson disease: from research setting to clinical practice.

Politis M.

Nat Rev Neurol. 2014 Dec;10(12):708-22. doi: 10.1038/nrneurol.2014.205. Epub 2014 Nov 11. Review.

PMID:
25385334
11.

The X-Linked Hypothesis of Brain Disorders: Can Gender Ratios Tell Us Anything About Cellular Etiology of Neurodegenerative and Psychiatric Diseases?

Turkheimer FE, Bodini B, Politis M, Pariante CM, Ciccarelli O, Yeo RA.

Neuroscientist. 2014 Aug 8. pii: 1073858414545999. [Epub ahead of print]

PMID:
25106640
12.

Serotonin in Parkinson's disease.

Politis M, Niccolini F.

Behav Brain Res. 2015 Jan 15;277:136-45. doi: 10.1016/j.bbr.2014.07.037. Epub 2014 Jul 31.

PMID:
25086269
13.

Neuroimaging in Huntington's disease.

Niccolini F, Politis M.

World J Radiol. 2014 Jun 28;6(6):301-12. doi: 10.4329/wjr.v6.i6.301. Review.

14.

Modeling proton-induced damage on 2-deoxy-D-ribose. Conformational analysis.

du Penhoat MA, López-Tarifa P, Ghose KK, Jeanvoine Y, Gaigeot MP, Vuilleumier R, Politis MF, Bacchus-Montabonel MC.

J Mol Model. 2014 May;20(5):2221. doi: 10.1007/s00894-014-2221-9. Epub 2014 May 9.

PMID:
24810462
15.

Dopamine receptor mapping with PET imaging in Parkinson's disease.

Niccolini F, Su P, Politis M.

J Neurol. 2014 Dec;261(12):2251-63. doi: 10.1007/s00415-014-7302-2. Epub 2014 Mar 15.

PMID:
24627109
16.

Problematic Internet use in Parkinson's disease.

Wu K, Politis M, O'Sullivan SS, Lawrence AD, Warsi S, Lees A, Piccini P.

Parkinsonism Relat Disord. 2014 May;20(5):482-7. doi: 10.1016/j.parkreldis.2014.01.019. Epub 2014 Feb 5.

PMID:
24582704
17.

PET in multiple sclerosis.

Niccolini F, Su P, Politis M.

Clin Nucl Med. 2015 Jan;40(1):e46-52. doi: 10.1097/RLU.0000000000000359. Review.

PMID:
24561681
18.

Serotonergic mechanisms responsible for levodopa-induced dyskinesias in Parkinson's disease patients.

Politis M, Wu K, Loane C, Brooks DJ, Kiferle L, Turkheimer FE, Bain P, Molloy S, Piccini P.

J Clin Invest. 2014 Mar;124(3):1340-9. doi: 10.1172/JCI71640. Epub 2014 Feb 17.

19.

The association of tobacco control policies and the risk of acute myocardial infarction using hospital admissions data.

Jan C, Lee M, Roa R, Herrera V, Politis M, Motta J.

PLoS One. 2014 Feb 10;9(2):e88784. doi: 10.1371/journal.pone.0088784. eCollection 2014.

20.

Microglia activation in multiple sclerosis black holes predicts outcome in progressive patients: an in vivo [(11)C](R)-PK11195-PET pilot study.

Giannetti P, Politis M, Su P, Turkheimer F, Malik O, Keihaninejad S, Wu K, Reynolds R, Nicholas R, Piccini P.

Neurobiol Dis. 2014 May;65:203-10. doi: 10.1016/j.nbd.2014.01.018. Epub 2014 Feb 6.

PMID:
24508617
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk